Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases
NCT07468513Phase 4Recruiting
- Sponsor
- Menzies School of Health Research
- Start
- May 2024
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 4, open-label trial of primaquine in vivax malaria (2 arms), sponsored by Menzies School of Health Research. Primary endpoint: Safety and Efficacy of Primaquine at 6 months. Started May 2024; status: recruiting.
02
Drugs
primaquine
03
Conditions
vivax malaria
Beyond the preview
Go deeper on NCT07468513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07468513.